Medtronic (MDT) Short term Debt (2014 - 2026)

Medtronic has disclosed Short term Debt across 13 years of filings, most recently posting $191.0 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $191.0 million, down 92.72% year-over-year; the trailing twelve-month figure through Jan 2026 was $191.0 million (down 92.72% YoY), and the FY2025 annual result was $2.9 billion, up 163.19% from the prior year.
• Short term Debt came in at $191.0 million for Q1 2026 at Medtronic, down from $1.4 billion in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $5.9 billion in Q1 2023 to a low of $20.0 million in Q2 2023.
• The 5-year median for Short term Debt is $1.6 billion (2024), against an average of $2.4 billion.
• Across the five-year window, Short term Debt jumped 95383.33% in 2022 and tumbled 99.47% in 2023, its largest moves.
• Medtronic's Short term Debt stood at $5.9 billion in 2022, then tumbled by 77.17% to $1.3 billion in 2023, then surged by 177.74% to $3.7 billion in 2024, then slumped by 61.82% to $1.4 billion in 2025, then tumbled by 86.55% to $191.0 million in 2026.
• The last three Short term Debt figures came in at $191.0 million (Q1 2026), $1.4 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.